Edwards Lifesciences Corp (EW):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Edwards Lifesciences Corp (EW) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7413
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Edwards Lifesciences Corp (Edwards) is a medical technology company, which focuses on the development, manufacture and marketing of products and technologies to treat structural heart disease, and help provide critical care and surgical monitoring. It develops and commercializes heart valve products such as heart valve systems and repair products aimed at the replacement or repair of a patient’s diseased or defective heart valve. The company also offers hemodynamic monitoring systems for the measurement of a patient’s cardiovascular function in a hospital setting. Edwards sells its products through direct sales force and a network of independent distributors across North America, Europe, Asia-Pacific and other regions. Edwards is headquartered in Irvine, California, the US.

Edwards Lifesciences Corp (EW) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Edwards Lifesciences Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Edwards Lifesciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Edwards Lifesciences Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Edwards Lifesciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Edwards Lifesciences Corp, Medical Equipment, Deal Details 12
Venture Financing 12
V-Wave Raises USD70 Million in Series C Financing 12
V-Wave Raises USD28 Million in Venture Financing 14
CardioKinetix Raises USD50 Million in Venture Financing 15
Harpoon Medical Raises USD3.2 Million in Series A Financing 16
Harpoon Medical Raises USD4 Million in Venture Financing 17
Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing 18
Partnerships 20
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 20
EndoEvolution Enters Into Licensing Agreement With Edwards Lifesciences For Endo360 21
Edwards Lifesciences Enters into Agreement with CareFusion 22
Equity Offering 23
Edwards Lifesciences Plans to Raise up to USD34.5 Million in Public Offering of Shares 23
Harpoon Medical Raises Funds through Private Placement 24
Debt Offering 25
Edwards Lifesciences Prices Public Offering of 4.3% Notes Due 2028 for USD600 Million 25
Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 26
Acquisition 28
Edwards Lifesciences Acquires Harpoon Medical 28
Edwards Lifesciences Acquires Valtech Cardio 29
Edwards Lifesciences Invests in Harpoon Medical 30
Edwards Lifesciences Acquires CardiAQ for USD400 Million 31
Edwards Lifesciences Receives an Option to Acquire CardioKinetix 32
Edwards Lifesciences Acquires Bmeye, Cardiovascular Monitoring Company, For US$42 Million 33
Edwards Lifesciences Corp – Key Competitors 35
Edwards Lifesciences Corp – Key Employees 36
Edwards Lifesciences Corp – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 40
Financial Announcements 40
Jul 26, 2018: Edwards Lifesciences Reports Second Quarter Results 40
Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 42
Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 44
Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 46
Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 48
Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 50
Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 52
Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 54
Corporate Communications 56
Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 56
May 18, 2017: Edwards Lifesciences’ Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020 57
Legal and Regulatory 58
Mar 28, 2018: Boston Scientific Prevails in U.K. Edwards Lifesciences Litigation 58
Product News 59
Apr 16, 2018: Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences 59
Mar 23, 2018: Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid 60
Other Significant Developments 61
Jan 29, 2018: Five devices for pediatrics get help in advancing to market 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Edwards Lifesciences Corp, Medical Equipment, Key Facts, 2017 2
Edwards Lifesciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Edwards Lifesciences Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Edwards Lifesciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Edwards Lifesciences Corp, Deals By Market, 2012 to YTD 2018 9
Edwards Lifesciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
V-Wave Raises USD70 Million in Series C Financing 12
V-Wave Raises USD28 Million in Venture Financing 14
CardioKinetix Raises USD50 Million in Venture Financing 15
Harpoon Medical Raises USD3.2 Million in Series A Financing 16
Harpoon Medical Raises USD4 Million in Venture Financing 17
Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing 18
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 20
EndoEvolution Enters Into Licensing Agreement With Edwards Lifesciences For Endo360 21
Edwards Lifesciences Enters into Agreement with CareFusion 22
Edwards Lifesciences Plans to Raise up to USD34.5 Million in Public Offering of Shares 23
Harpoon Medical Raises Funds through Private Placement 24
Edwards Lifesciences Prices Public Offering of 4.3% Notes Due 2028 for USD600 Million 25
Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 26
Edwards Lifesciences Acquires Harpoon Medical 28
Edwards Lifesciences Acquires Valtech Cardio 29
Edwards Lifesciences Invests in Harpoon Medical 30
Edwards Lifesciences Acquires CardiAQ for USD400 Million 31
Edwards Lifesciences Receives an Option to Acquire CardioKinetix 32
Edwards Lifesciences Acquires Bmeye, Cardiovascular Monitoring Company, For US$42 Million 33
Edwards Lifesciences Corp, Key Competitors 35
Edwards Lifesciences Corp, Key Employees 36
Edwards Lifesciences Corp, Other Locations 37
Edwards Lifesciences Corp, Subsidiaries 37

List of Figures
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Edwards Lifesciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Edwards Lifesciences Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Edwards Lifesciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Edwards Lifesciences Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Edwards Lifesciences Corp (EW):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • mAbxience SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the treatment and prevention of various diseases in onclology such as breast c …
  • Kot Addu Power Co Ltd:発電所・企業SWOT分析
    Kot Addu Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Cynosure Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • Archer Ltd (ARCHER):企業の財務・戦略的SWOT分析
    Archer Ltd (ARCHER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Cytori Therapeutics Inc (CYTX)-医療機器分野:企業M&A・提携分析
    Summary Cytori Therapeutics Inc (Cytori) is a clinical stage regenerative medicine company. It develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two …
  • Snowy Hydro Ltd:電力:M&Aディール及び事業提携情報
    Summary Snowy Hydro Ltd (Snowy Hydro) is an integrated energy utility. It has presence in the energy vertical, from generating energy, providing price risk management products for wholesale customers, and delivering energy to homes and businesses. The company produces electricity from gas, hydro, an …
  • Diagnostics For All Inc:企業の製品パイプライン分析
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Basware Oyj (BAS1V):企業の財務・戦略的SWOT分析
    Basware Oyj (BAS1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cleco Corporate Holdings LLC:企業の発電所・SWOT分析2018
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Pharming Group NV (PHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company’s flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for …
  • The Depository Trust & Clearing Corporation:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Pentair Plc (PNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • Dome Energy AB (DOME):石油・ガス:M&Aディール及び事業提携情報
    Summary Dome Energy AB (Dome Energy), formerly Commodity Quest AB is an oil and gas company that exploits, explores, develops and produces conventional oil and gas reserves. The company explores for onshore oil and gas fields to identify unexploited well locations. It explores and produces oil and g …
  • Orange Polska S.A.:企業の戦略・SWOT・財務情報
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …
  • Calamos Asset Management, Inc.
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Berkshire Hathaway Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • BlackRock Inc:戦略・SWOT・企業財務分析
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆